Literature DB >> 17729072

Activity limitation and quality of life in COPD.

Paul W Jones1.   

Abstract

Limitation of activity and impaired quality of life are important outcomes of COPD. There is an association between measures of self-reported physical activity and overall health status, and they appear to change together spontaneously over time and in response to treatment. The relationship between symptoms and activity limitation is complex, because activity can be limited entirely by symptoms, or impaired by symptoms so that it requires greater effort or causes discomfort. The patient has the choice of whether to restrict their activity or maintain it at the cost of having symptoms. In theory, this may make it difficult to produce reliable standardized assessments of activity limitation because it may not be clear exactly what is being measured. Analysis of items in the St George's Respiratory Questionnaire (SGRQ) concerned with activities that are either not possible due to breathlessness, or are a cause of breathlessness, show that they contribute to a unidimensional model of activity limitation in daily life and a unidimensional model of overall COPD-related health status. The items lie distributed evenly along the same severity continuum, from very mild to very severe, along with other items concerned with symptoms and the psycho-social impact of the disease. This suggests that self-reported limitation of activity may form a reliable construct, and may also provide a good surrogate marker of health status in COPD.

Entities:  

Mesh:

Year:  2007        PMID: 17729072     DOI: 10.1080/15412550701480265

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  19 in total

1.  HIV and COPD: impact of risk behaviors and diseases on quality of life.

Authors:  M Bradley Drummond; Gregory D Kirk; Meredith C McCormack; Mariah M Marshall; Erin P Ricketts; Shruti H Mehta; Robert A Wise; Christian A Merlo
Journal:  Qual Life Res       Date:  2010-07-09       Impact factor: 4.147

2.  A new mode of community continuing care service for COPD patients in China: participation of respiratory nurse specialists.

Authors:  Pingdong Li; Yucui Gong; Guangqiao Zeng; Liang Ruan; Guifen Li
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Collateral damage: depressive symptoms in the partners of COPD patients.

Authors:  Andriana I Papaioannou; Stamatoula Tsikrika; Konstantinos Bartziokas; Foteini Karakontaki; Emmanouil Kastanakis; Filia Diamantea; Aikaterini Haniotou; Spyros Papiris; Vlassis Polychronopoulos; Stelios Loukides; Konstantinos Kostikas
Journal:  Lung       Date:  2014-05-11       Impact factor: 2.584

Review 4.  Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges.

Authors:  Vanessa M McDonald; Isabel Higgins; Peter G Gibson
Journal:  Drugs Aging       Date:  2013-01       Impact factor: 3.923

Review 5.  An integrative review of systematic reviews related to the management of breathlessness in respiratory illnesses.

Authors:  Chris D Bailey; Richard Wagland; Rasha Dabbour; Ann Caress; Jaclyn Smith; Alex Molassiotis
Journal:  BMC Pulm Med       Date:  2010-12-09       Impact factor: 3.317

6.  A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.

Authors:  Robert Wilson; Antonio Anzueto; Marc Miravitlles; Pierre Arvis; Geneviève Faragó; Daniel Haverstock; Mila Trajanovic; Sanjay Sethi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-06-29

7.  Factors associated with good self-rated health and quality of life in subjects with self-reported COPD.

Authors:  Mats Arne; Fredrik Lundin; Gunnar Boman; Christer Janson; Staffan Janson; Margareta Emtner
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-10-07

Review 8.  Pathogenesis of hyperinflation in chronic obstructive pulmonary disease.

Authors:  Philippe Gagnon; Jordan A Guenette; Daniel Langer; Louis Laviolette; Vincent Mainguy; François Maltais; Fernanda Ribeiro; Didier Saey
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-02-15

9.  Patient characteristics, treatment patterns, and health outcomes among COPD phenotypes.

Authors:  Felicia C Allen-Ramey; Shaloo Gupta; Marco DaCosta DiBonaventura
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-11-22

10.  Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom.

Authors:  Yevgeniy Samyshkin; Robert W Kotchie; Ann-Christin Mörk; Andrew H Briggs; Eric D Bateman
Journal:  Eur J Health Econ       Date:  2013-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.